FDA advisory panel backs COVID-19 boosters only for elderly, high-risk

Members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.

Posted: Sep 17, 2021 2:37 PM
Updated: Sep 17, 2021 3:37 PM

WASHINGTON (AP) - An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it approved the extra shots for those who are 65 or older or run a high risk of severe disease.

The twin votes Friday represented a heavy blow to the Biden administration’s sweeping effort to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant.

The decision was made by a committee of outside experts who advise the Food and Drug Administration.

Huntsville
Cloudy
58° wxIcon
Hi: 74° Lo: 57°
Feels Like: 58°
Florence
Cloudy
61° wxIcon
Hi: 75° Lo: 57°
Feels Like: 61°
Fayetteville
Cloudy
57° wxIcon
Hi: 75° Lo: 58°
Feels Like: 57°
Decatur
Cloudy
57° wxIcon
Hi: 77° Lo: 57°
Feels Like: 57°
Scottsboro
Cloudy
61° wxIcon
Hi: 75° Lo: 57°
Feels Like: 61°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Community Events